{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:00:01Z","timestamp":1773666001218,"version":"3.50.1"},"reference-count":61,"publisher":"Akademiai Kiado Zrt.","issue":"22","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:p>A palliat\u00edv ell\u00e1t\u00e1s sor\u00e1n a termin\u00e1lis \u00e1llapot\u00fa betegek megfelel\u0151 t\u00fcneti ell\u00e1t\u00e1sa\n                    j\u00f3l \u00e1tgondolt gy\u00f3gyszeradagol\u00e1st ig\u00e9nyel. A betegek nagy r\u00e9sze otthon\u00e1ban\n                    szeretn\u00e9 t\u00f6lteni \u00e9lete utols\u00f3 id\u0151szak\u00e1t, amit a megfelel\u0151en megv\u00e1lasztott\n                    gy\u00f3gyszerbeviteli \u00fat t\u00e1mogathat, elker\u00fclve \u00edgy az indokolatlan hospitaliz\u00e1ci\u00f3t.\n                    El\u0151nyben r\u00e9szes\u00edtend\u0151 az or\u00e1lis gy\u00f3gyszerbevitel, de ahogy a beteg az \u00e9letv\u00e9gi\n                    ell\u00e1t\u00e1s fel\u00e9 halad, sz\u00e1mos okb\u00f3l kifoly\u00f3lag ez \u00e1tmenetileg vagy v\u00e9glegesen\n                    lehetetlenn\u00e9 v\u00e1lik. A beteg \u00e9s a csal\u00e1d k\u00edv\u00e1ns\u00e1g\u00e1t szem el\u0151tt tartva, a kor\u00e1bbi\n                    \u00e9s a jelenlegi t\u00fcnetek figyelembev\u00e9tel\u00e9vel kell megb\u00edzhat\u00f3, hat\u00e9kony\n                    gy\u00f3gyszerbeviteli utat v\u00e1lasztani, amely nem korl\u00e1tozza a betegek mindennapi\n                    aktivit\u00e1s\u00e1t. A transdermalis gy\u00f3gyszerbevitel k\u00f6nny\u0171, k\u00e9nyelmes, a hossz\u00fa\n                    felez\u00e9si idej\u0171 opioid f\u00e1jdalomcsillap\u00edt\u00f3 tapaszok els\u0151sorban stabil f\u00e1jdalmak\n                    csillap\u00edt\u00e1s\u00e1ban javasoltak. Az or\u00e1lis transmucosalis gy\u00f3gyszeradagol\u00e1s j\u00f3\n                    alternat\u00edva lehet az utols\u00f3 id\u0151szak ell\u00e1t\u00e1s\u00e1ban, p\u00e9ld\u00e1ul \u00e1tt\u00f6r\u00e9ses f\u00e1jdalmak\n                    csillap\u00edt\u00e1s\u00e1ban. A rectalis gy\u00f3gyszeradagol\u00e1s k\u00f6lts\u00e9ghat\u00e9kony, otthon is k\u00f6nnyen\n                    kivitelezhet\u0151, kev\u00e9sb\u00e9 invaz\u00edv m\u00f3dszer. A subcutan gy\u00f3gyszeradagol\u00e1s sor\u00e1n\n                    bolus- \u00e9s folyamatos 24 \u00f3r\u00e1s gy\u00f3gyszeradagol\u00e1sra (continuous subcutaneous\n                    infusion) is lehet\u0151s\u00e9g van. A hordozhat\u00f3 subcutan inf\u00fazi\u00f3s pumpa (syringe\n                    driver) fontos r\u00e9sz\u00e9t k\u00e9pezi a t\u00fcneti kezel\u00e9snek az \u00e9let v\u00e9g\u00e9n. Felk\u00e9sz\u00fclt,\n                    szakszem\u00e9lyzet \u00e1ltal eduk\u00e1lt hozz\u00e1tartoz\u00f3k k\u00f6zrem\u0171k\u00f6d\u00e9s\u00e9vel hat\u00e9kony \u00e9s\n                    biztons\u00e1gos gy\u00f3gyszerbevitel kivitelezhet\u0151, amely jobb t\u00fcneti kontrollt\n                    biztos\u00edt, ez\u00e1ltal a k\u00f3rh\u00e1zi beutal\u00e1sok sz\u00e1ma cs\u00f6kkenthet\u0151, a beteg \u00e9s csal\u00e1dja\n                    \u00e1ltal prefer\u00e1lt otthoni \u00e9letv\u00e9gi ell\u00e1t\u00e1s sok esetben biztos\u00edthat\u00f3. Orv Hetil.\n                    2025; 166(22): 839\u2013846.<\/jats:p>","DOI":"10.1556\/650.2025.33292","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T23:24:58Z","timestamp":1748906698000},"page":"839-846","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":2,"title":["Alternat\u00edv gy\u00f3gyszerbeviteli m\u00f3dok a palliat\u00edv ell\u00e1t\u00e1s sor\u00e1n"],"prefix":"10.1556","volume":"166","author":[{"given":"N\u00f3ra","family":"Frank","sequence":"first","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Alapell\u00e1t\u00e1si Int\u00e9zet, Hospice-Palliat\u00edv Tansz\u00e9k P\u00e9cs Magyarorsz\u00e1g"},{"name":"P\u00e9csi Tudom\u00e1nyegyetem, Eg\u00e9szs\u00e9gtudom\u00e1nyi Kar, Eg\u00e9szs\u00e9gtudom\u00e1nyi Doktori Iskola P\u00e9cs Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00f3ra","family":"Szigeti","sequence":"additional","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Klinikai K\u00f6zpont, II. Belgy\u00f3gy\u00e1szati Klinika \u00e9s Nephrol\u00f3giai, Diabetol\u00f3giai Centrum P\u00e9cs, Pacsirta u. 1., 7624 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs","family":"F\u00fcl\u00f6p","sequence":"additional","affiliation":[{"name":"P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Alapell\u00e1t\u00e1si Int\u00e9zet, Hospice-Palliat\u00edv Tansz\u00e9k P\u00e9cs Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"ref0","unstructured":"1 Beny\u00f3 G, Luk\u00e1cs M, Busa Cs, et al. Current situation of palliative care in Hungary. Integrated palliative care model as a breakout possibility. [A magyarorsz\u00e1gi palliat\u00edv-hospice ell\u00e1t\u00e1s helyzete, kih\u00edv\u00e1sai, kit\u00f6r\u00e9si pontjai.] Magy Onkol. 2017; 61: 292-299. [Hungarian]"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.canep.2019.02.015","article-title":"Wait times to diagnosis and treatment in patients with colorectal cancer in Hungary","volume":"59","author":"2 Pozsgai","year":"2019","unstructured":"2 Pozsgai E, Busa C, Fodor D, et al. Wait times to diagnosis and treatment in patients with colorectal cancer in Hungary. Cancer Epidemiol. 2019; 59: 244-248.","journal-title":"Cancer Epidemiol"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3 Heged\u00fcs K, Luk\u00e1cs M, Schaffer J, et al. The current state, the possibilities and difficulties of palliative and hospice care in Hungary. [A hazai hospice- \u00e9s palliat\u00edv ell\u00e1t\u00e1s helyzete, lehet\u0151s\u00e9gei, neh\u00e9zs\u00e9gei.] Orv Hetil. 2014; 155: 1504-1509. [Hungarian]","DOI":"10.1556\/OH.2014.29995"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/bjc.2015.312","article-title":"International study of the place of death of people with cancer: a population-level comparison of 14 countries across 4 continents using death certificate data","volume":"113","author":"4 Cohen","year":"2015","unstructured":"4 Cohen J, Pivodic L, Miccinesi G, et al. International study of the place of death of people with cancer: a population-level comparison of 14 countries across 4 continents using death certificate data. Br J Cancer 2015; 113: 1397-1404.","journal-title":"Br J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1089\/jpm.2008.0094","article-title":"Hungarians' perspectives on end-of-life care","volume":"11","author":"5 Csikos","year":"2008","unstructured":"5 Csikos A, Albanese T, Busa C, et al. Hungarians' perspectives on end-of-life care. J Palliat Med. 2008; 11: 1083-1087.","journal-title":"J Palliat Med"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6 Csik\u00f3s \u00c1, Nagy L, Busa Cs, et al. Important aspects of end-of-life care. Survey of patients visiting the primary care office. [Az \u00e9letv\u00e9gi ell\u00e1t\u00e1s fontos k\u00e9rd\u00e9sei. Attit\u0171dvizsg\u00e1lat h\u00e1ziorvoshoz fordul\u00f3 betegek k\u00f6r\u00e9ben.] Orv Hetil. 2011; 152: 1082-1092. [Hungarian]","DOI":"10.1556\/OH.2011.29139"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/jech-2014-205365","article-title":"Place of death in the population dying from diseases indicative of palliative care need: a cross-national population-level study in 14 countries","volume":"70","author":"7 Pivodic","year":"2016","unstructured":"7 Pivodic L, Pardon K, Morin L, et al. Place of death in the population dying from diseases indicative of palliative care need: a cross-national population-level study in 14 countries. J Epidemiol Community Health 2016; 70: 17-24.","journal-title":"J Epidemiol Community Health"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8 Busa Cs, Zeller J, Csik\u00f3s \u00c1. Who should decide at the end of life? International practice of advance care planning and possibilities for adaptation in Hungary. [Ki d\u00f6nts\u00f6n az \u00e9let v\u00e9g\u00e9n? Az ell\u00e1t\u00e1s el\u0151zetes tervez\u00e9s\u00e9nek nemzetk\u00f6zi gyakorlata \u00e9s hazai lehet\u0151s\u00e9gei.] Orv Hetil. 2018; 159: 131-140. [Hungarian]","DOI":"10.1556\/650.2018.30937"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/02813432.2022.2057055","article-title":"Who should talk with patients about their end-of-life care wishes? A nationwide survey of the Hungarian population","volume":"40","author":"9 Busa","year":"2022","unstructured":"9 Busa C, Pozsgai E, Zeller J, et al. Who should talk with patients about their end-of-life care wishes? A nationwide survey of the Hungarian population. Scand J Prim Health Care 2022; 40: 157-164.","journal-title":"Scand J Prim Health Care"},{"key":"ref9","unstructured":"10 Busa C, Zeller J, Csik\u00f3s \u00c1. Prevailing opinions and knowledge about end-of-life decision making with the Hungarian population. [\u00c9letv\u00e9gi k\u00edv\u00e1nalmakkal \u00e9s d\u00f6nt\u00e9sekkel kapcsolatos v\u00e9lem\u00e9nyek \u00e9s ismeretek a magyar t\u00e1rsadalomban.] Khar\u00f3n Thanatol\u00f3giai Szle. 2018; 22(3): 9-26. [Hungarian]"},{"key":"ref10","unstructured":"11 Heged\u0171s K, Luk\u00e1cs M. Hospice care in 2023 - based on the data of the National Health Insurance Fund and the Hungarian Hospice-Palliative Association. [Hospice betegell\u00e1t\u00e1s 2023 a Nemzeti Eg\u00e9szs\u00e9gbiztos\u00edt\u00e1si Alapkezel\u0151 \u00e9s a Magyar Hospice-Palliat\u00edv Egyes\u00fclet adatai alapj\u00e1n.] Khar\u00f3n Thanatol\u00f3giai Szle. 2024; 28(3): 1-13. [Hungarian]"},{"key":"ref11","unstructured":"12 Frank N. Routes of drug administration, infusion pump. In: Csik\u00f3s \u00c1. (ed.) Palliative care. [Gy\u00f3gyszerbeviteli m\u00f3dok, inf\u00fazi\u00f3s pumpa. In: Csik\u00f3s \u00c1. (szerk.) Palliat\u00edv ell\u00e1t\u00e1s.] Medicina K\u00f6nyvkiad\u00f3, Budapest, 2022; pp. 427-435. [Hungarian]"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13 Shepperd S, Gon\u00e7alves-Bradley DC, Straus SE, et al. Hospital at home: home-based end-of-life care. Cochrane Database Syst Rev. 2021; 3: CD009231.","DOI":"10.1002\/14651858.CD009231.pub3"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/0885-3924(96)00012-7","article-title":"Practical use of rectal medications in palliative care","volume":"11","author":"14 Warren","year":"1996","unstructured":"14 Warren DE. Practical use of rectal medications in palliative care. J Pain Symptom Manage 1996; 11: 378-387.","journal-title":"J Pain Symptom Manage"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15 Van Hoogdalem EJ, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration. Part I. General considerations and clinical applications of centrally acting drugs. Clin Pharmacokinet. 1991; 21: 11-26.","DOI":"10.2165\/00003088-199121010-00002"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/22103031113039990011","article-title":"Transmucosal drug delivery - an overview","volume":"4","author":"16 Abhang","year":"2014","unstructured":"16 Abhang P, Momin M, Inamdar M, et al. Transmucosal drug delivery - an overview. Drug Delivery Lett. 2014; 4: 26-37.","journal-title":"Drug Delivery Lett"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/JPR.S3865","article-title":"A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet","volume":"2","author":"17 Freye","year":"2008","unstructured":"17 Freye E. A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet. J Pain Res. 2008; 2: 13-20.","journal-title":"J Pain Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jpainsymman.2013.10.018","article-title":"Subcutaneous administration of drugs in palliative care: results of a systematic observational study","volume":"48","author":"18 Bartz","year":"2014","unstructured":"18 Bartz L, Klein C, Seifert A, et al. Subcutaneous administration of drugs in palliative care: results of a systematic observational study. J Pain Symptom Manage 2014; 48: 540-547.","journal-title":"J Pain Symptom Manage"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00520-001-0311-6","article-title":"Symptom control in cancer patients: The clinical pharmacology and therapeutic role of suppositories and rectal suspensions","volume":"10","author":"19 Davis","year":"2002","unstructured":"19 Davis MP, Walsh D, LeGrand SB, et al. Symptom control in cancer patients: The clinical pharmacology and therapeutic role of suppositories and rectal suspensions. Support Care Cancer 2002; 10: 117-138.","journal-title":"Support Care Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/pme.12464","article-title":"Alternative routes to oral opioid administration in palliative care: a review and clinical summary","volume":"15","author":"20 Kestenbaum","year":"2014","unstructured":"20 Kestenbaum MG, Vilches AO, Messersmith S, et al. Alternative routes to oral opioid administration in palliative care: a review and clinical summary. Pain Med. 2014; 15: 1129-1153.","journal-title":"Pain Med"},{"key":"ref20","unstructured":"21 Frank N. Steroid therapy. In: Csik\u00f3s \u00c1. (ed.) Palliative care. [Szteroidter\u00e1pia. In: Csik\u00f3s \u00c1. (szerk.) Palliat\u00edv ell\u00e1t\u00e1s.] Medicina K\u00f6nyvkiad\u00f3, Budapest, 2022; pp. 290-295. [Hungarian]"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0885-3924(02)00487-6","article-title":"A retrospective observation of corticosteroid use at the end of life in a hospice","volume":"24","author":"Gannon C","year":"2002","unstructured":"22 Gannon C, McNamara P. A retrospective observation of corticosteroid use at the end of life in a hospice. J Pain Symptom Manage 2002; 24: 328-334.","journal-title":"J Pain Symptom Manage"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23 Barkin RL. The pharmacology of topical analgesics. Postgrad Med. 2013; 125(4 Suppl 1): 7-18.","DOI":"10.1080\/00325481.2013.1110566911"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24 McCarberg B, D'Arcy Y. Options in topical therapies in the management of patients with acute pain. Postgrad Med. 2013; 125(4 Suppl 1): 19-24.","DOI":"10.1080\/00325481.2013.1110567011"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25 Stanos SP, Galluzzi KE. Topical therapies in the management of chronic pain. Postgrad Med. 2013; 125(4 Suppl 1): 25-33.","DOI":"10.1080\/00325481.2013.1110567111"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/00325481.2019.1702296","article-title":"Utility of lidocaine as a topical analgesic and improvements in patch delivery systems","volume":"132","author":"Gudin J","year":"2020","unstructured":"26 Gudin J, Nalamachu S. Utility of lidocaine as a topical analgesic and improvements in patch delivery systems. Postgrad Med. 2020; 132: 28-36.","journal-title":"Postgrad Med"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27 Csikos A, Busa C, Muszbek K. Hospice palliative care development in Hungary. J Pain Symptom Manage 2018; 55: S30-S35.","DOI":"10.1016\/j.jpainsymman.2017.03.034"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.2147\/JPR.S140320","article-title":"Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review","volume":"10","author":"28 Ahn","year":"2017","unstructured":"28 Ahn JS, Lin J, Ogawa S, et al. Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review. J Pain Res. 2017; 10: 1963-1972.","journal-title":"J Pain Res"},{"key":"ref28","unstructured":"29 Csik\u00f3s \u00c1. Basics, current situation and challenges of palliative care. In: Csik\u00f3s \u00c1. (ed.) Palliative care. [A palliat\u00edv ell\u00e1t\u00e1s alapjai, jelenlegi helyzete \u00e9s kih\u00edv\u00e1sai. In: Csik\u00f3s \u00c1. (szerk.) Palliat\u00edv ell\u00e1t\u00e1s.] Medicina K\u00f6nyvkiad\u00f3, Budapest, 2022; pp. 36-52. [Hungarian]"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"8610538","DOI":"10.1155\/2018\/8610538","article-title":"Differences between transdermal fentanyl and buprenorphine in the elderly hospice patients","volume":"2018","author":"30 Gol\u010di\u0107","year":"2018","unstructured":"30 Gol\u010di\u0107 M, Dobrila-Dintinjana R, Gol\u010di\u0107 G, et al. Differences between transdermal fentanyl and buprenorphine in the elderly hospice patients. Pain Res Treat. 2018; 2018: 8610538.","journal-title":"Pain Res Treat"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31 Hadley G, Derry S, Moore RA, et al. Transdermal fentanyl for cancer pain. Cochrane database Syst Rev. 2013; 2013: CD010270.","DOI":"10.1002\/14651858.CD010270"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32 Wang DD, Ma TT, Zhu HD, et al. Transdermal fentanyl for cancer pain: trial sequential analysis of 3406 patients from 35 randomized controlled trials. J Cancer Res Ther. 2018; 14(Suppl): S14-S21.","DOI":"10.4103\/0973-1482.171368"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.pain.2009.04.012","article-title":"Transdermal fentanyl in cachectic cancer patients","volume":"144","author":"33 Heiskanen","year":"2009","unstructured":"33 Heiskanen T, M\u00e4tzke S, Haakana S, et al. Transdermal fentanyl in cachectic cancer patients. Pain 2009; 144: 218-222.","journal-title":"Pain"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jpainsymman.2007.01.006","article-title":"Switching from transdermal drugs: an obstervational 'N of 1' study of fentanyl and buprenorphine","volume":"34","author":"34 Mercadante","year":"2007","unstructured":"34 Mercadante S, Porzio G. Fulfaro F, et al. Switching from transdermal drugs: an obstervational 'N of 1' study of fentanyl and buprenorphine. J Pain Symptom Manag. 2007; 34: 532-538.","journal-title":"J Pain Symptom Manag"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1533-2500.2010.00378.x","article-title":"Current knowledge of buprenorphine and its unique pharmacological profile","volume":"10","author":"35 Pergolizzi","year":"2010","unstructured":"35 Pergolizzi J, Aloisi AM, Dahan A, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract. 2010; 10: 428-450.","journal-title":"Pain Pract"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1185\/03007990902920731","article-title":"The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus","volume":"25","author":"Pergolizzi JV Jr","year":"2009","unstructured":"36 Pergolizzi JV Jr, Mercadante S, Echaburu AV, et al. The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus. Curr Med Res Opin. 2009; 25: 1517-1528.","journal-title":"Curr Med Res Opin"},{"key":"ref36","unstructured":"37 Routes of Medication Administration - The Macy Catheter. Available from: https:\/\/www.macycatheter.com\/alternate-routes-medication-administration\/ [accessed: Sep 17, 2024]."},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38 Aabom B, Laier G, Christensen PL, et al. Oral morphine drops for prompt relief of breathlessness in patients with advanced cancer - a randomized, double blinded, crossover trial of morphine sulfate oral drops vs. morphine hydrochloride drops with ethanol (red morphine drops). Support Care Cancer 2020; 28: 3421-3428.","DOI":"10.1007\/s00520-019-05116-1"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0304-3959(99)00006-8","article-title":"Breakthrough pain: characteristics and impact in patients with cancer pain","volume":"81","author":"39 Portenoy","year":"1999","unstructured":"39 Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999; 81: 129-134.","journal-title":"Pain"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0304-3959(90)90004-W","article-title":"Breakthrough pain: definition, prevalence and characteristics","volume":"41","author":"Portenoy RK","year":"1990","unstructured":"40 Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain 1990; 41: 273-281.","journal-title":"Pain"},{"key":"ref40","unstructured":"41 Csik\u00f3s \u00c1. Magistral recipies. In: Csik\u00f3s \u00c1. (ed.) Palliative care. [Magisztr\u00e1lis receptek. In: Csik\u00f3s \u00c1. (szerk.) Palliat\u00edv ell\u00e1t\u00e1s.] Medicina K\u00f6nyvkiad\u00f3, Budapest, 2022; pp. 573-577. [Hungarian]"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42 Zeppetella G, Davies AN. Opioids for the management of breakthrough pain in cancer patients. Cochrane Database Syst Rev. 2015; 2015: CD004311.","DOI":"10.1002\/14651858.CD004311.pub4"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.2217\/fon-2021-1639","article-title":"Low-dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain in palliative care","volume":"18","author":"43 Rodr\u00edguez","year":"2022","unstructured":"43 Rodr\u00edguez AT, Viejo MN, Maradey P, et al. Low-dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain in palliative care. Future Oncol. 2022; 18: 1717-1731.","journal-title":"Future Oncol"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44 Sittl R. Transdermal buprenorphine in cancer pain and palliative care. Palliat Med. 2006; 20(Suppl 1): S25-S30.","DOI":"10.1191\/0269216306pm1125oa"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45 Van Hoogdalem EJ, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration. Part II: Clinical applications of peripherally acting drugs, and conclusions. Clin Pharmacokinet. 1991; 21: 110-128.","DOI":"10.2165\/00003088-199121020-00003"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2165\/00003088-198207040-00002","article-title":"Rectal drug administration: clinical pharmacokinetic considerations","volume":"7","author":"Boer AG","year":"1982","unstructured":"46 De Boer AG, Moolenaar F, de Leede LG, et al. Rectal drug administration: clinical pharmacokinetic considerations. Clin Pharmacokinet. 1982; 7: 285-311.","journal-title":"Clin Pharmacokinet"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47 Subbiah IM, Charone MM, Roszik J, et al. Association of Edmonton symptom assessment system global distress score with overall survival in patients with advanced cancer. JAMA Netw Open 2021; 4: e2117295.","DOI":"10.1001\/jamanetworkopen.2021.17295"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48 Moolenaar F, Oldenhof NJ, Groenewoud W, et al. Biopharmaceutics of rectal administration of drugs in man. Absorption rate and bioavailability of acetylsalicylic acid and its calcium salt after oral and rectal administration. Pharm Weekbl Sci Ed. 1979; 1: 1459-1469.","DOI":"10.1007\/BF02293485"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/15360288.2018.1500509","article-title":"A cost and quality analysis of utilizing a rectal catheter for medication administration in end-of-life symptom management","volume":"32","author":"49 Latuga","year":"2018","unstructured":"49 Latuga NM, Gordon M, Farwell P, et al. A cost and quality analysis of utilizing a rectal catheter for medication administration in end-of-life symptom management. J Pain Palliat Care Pharmacother. 2018; 32: 63-70.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/17434440.2018.1481744","article-title":"Evaluation of the Macy catheter\u00ae: a rectal catheter for rapid medication and fluid administration","volume":"15","author":"50 Macygin","year":"2018","unstructured":"50 Macygin KM, Kulstad E, Mokszycki RK, et al. Evaluation of the Macy catheter\u00ae: a rectal catheter for rapid medication and fluid administration. Expert Rev Med Devices 2018; 15: 407-414.","journal-title":"Expert Rev Med Devices"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1188\/20.CJON.689-693","article-title":"Macy catheter: integration and evaluation in a hospice setting to provide symptom relief during end-of-life care","volume":"24","author":"51 Quinlin","year":"2020","unstructured":"51 Quinlin L, Schmitz W, Jefferson M. Macy catheter: integration and evaluation in a hospice setting to provide symptom relief during end-of-life care. Clin J Oncol Nurs. 2020; 24: 689-693.","journal-title":"Clin J Oncol Nurs"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"52 Dickman A, Schneider J. (eds.) The Syringe Driver. Continuous subcutaneous infusions in palliative care (4 edn). Oxford University Press, Oxford, 2016.","DOI":"10.1093\/med\/9780198733720.001.0001"},{"key":"ref52","unstructured":"53 Frank N. Fluid therapy et the end of life. In: Csik\u00f3s \u00c1. (ed.) Palliative care. [Folyad\u00e9kter\u00e1pia az \u00e9let v\u00e9g\u00e9n. In: Csik\u00f3s \u00c1. (szerk.) Palliat\u00edv ell\u00e1t\u00e1s.] Medicina K\u00f6nyvkiad\u00f3, Budapest, 2022; pp. 447-451. [Hungarian]"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/NAN.0b013e3181922552","article-title":"Hypodermoclysis in the home and long-term care settings","volume":"32","author":"54 Lybarger","year":"2009","unstructured":"54 Lybarger EH. Hypodermoclysis in the home and long-term care settings. J Infus Nurs. 2009; 32: 40-44.","journal-title":"J Infus Nurs"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/1049909119897401","article-title":"Hypodermoclysis as a strategy for patients with end-of-life cancer in home care settings","volume":"37","author":"55 Coelho","year":"2020","unstructured":"55 Coelho TA, Wainstein AJ, Drummond-Lage AP. Hypodermoclysis as a strategy for patients with end-of-life cancer in home care settings. Am J Hosp Palliat Care 2020; 37: 675-682.","journal-title":"Am J Hosp Palliat Care"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1177\/02692163221082245","article-title":"Investigating the benefits and harms of hypodermoclysis of patients in palliative care: a consecutive cohort study","volume":"36","author":"56 Agar","year":"2022","unstructured":"56 Agar MR, Chang S, Amgarth-Duff I, et al. Investigating the benefits and harms of hypodermoclysis of patients in palliative care: a consecutive cohort study. Palliat Med. 2022; 36: 830-840.","journal-title":"Palliat Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/02692163231220225","article-title":"An international Delphi study","volume":"38","author":"57 Surges","year":"2024","unstructured":"57 Surges SM, Brunsch H, Jaspers B, et al. Revised European Association for Palliative Care (EAPC) recommended framework on palliative sedation. An international Delphi study. Palliat Med. 2024; 38: 213-228.","journal-title":"Palliat Med"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"58 Thomas B. Phenobarbital sedation via subcutaneous infusion in a palliative medicine unit: retrospective review. BMJ Support Palliat Care 2023; 13: e262-e263.","DOI":"10.1136\/bmjspcare-2021-003263"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"59 Arantzamendi M, Belar A, Payne S, et al. Clinical aspects of palliative sedation in prospective studies. A systematic review. J Pain Symptom Manage 2021; 61: 831-844.e10.","DOI":"10.1016\/j.jpainsymman.2020.09.022"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"60 Varga G, Horv\u00e1th R, Busa Cs, et al. Assessment of anxiety, depression, and physical symptoms and understanding of their connections among cancer patients. [Szorong\u00e1s, depresszi\u00f3, valamint fizikai t\u00fcneti terhek felm\u00e9r\u00e9se \u00e9s \u00f6sszef\u00fcgg\u00e9seik megismer\u00e9se daganatos betegek k\u00f6r\u00e9ben.] Orv Hetil. 2024; 165: 309-317. [Hungarian]","DOI":"10.1556\/650.2024.32984"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"61 Fortuna J, Luk\u00e1cs M, Busa Cs. Opportunities for the use of telemedicine in home hospice care: lessons learned from the COVID-19 pandemic. [A telemedicina alkalmaz\u00e1si lehet\u0151s\u00e9gei az otthoni hospice-ell\u00e1t\u00e1sban, avagy mit tanultunk a COVID-19-pand\u00e9mi\u00e1b\u00f3l?] Orv Hetil. 2024; 165: 1579-1586. [Hungarian]","DOI":"10.1556\/650.2024.32991"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/166\/22\/article-p839.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/166\/22\/article-p839.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/166\/22\/article-p839.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T08:47:23Z","timestamp":1760518043000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/166\/22\/article-p839.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":61,"journal-issue":{"issue":"22"},"URL":"https:\/\/doi.org\/10.1556\/650.2025.33292","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}